Showing results (1001-1010 of 2,816) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|February 3, 2025
Glycemic Control Across the Menstrual Cycle in Women with Type 1 Diabetes Using the MiniMed 780G Advanced Hybrid Closed-Loop System: The 780MENS Prospective StudyGabriela Monroy, María José Picón-César, Jorge García-Alemán, et al.Diabetes Technology & Therapeutics|February 6, 2025
Age-Dependent Bolus Settings: Insulin-to-Carbohydrate Ratios and Insulin Sensitivity Factors in Pediatric Patients with Type 1 Diabetes on Conventional CSII in the DPV RegistryChristina Reinauer, Alena Welters, Mareike Niemeyer, et al.Diabetes Technology & Therapeutics|January 27, 2025
Evaluation of Accuracy and Safety of the 365-Day Implantable Eversense Continuous Glucose Monitoring System: The ENHANCE StudyTimothy S Bailey, David R Liljenquist, Douglas S Denham, et al.Diabetes Technology & Therapeutics|January 6, 2025
A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive CohortsJay M Sosenko, David Cuthbertson, Laura M Jacobsen, et al.Diabetes Technology & Therapeutics|January 9, 2025
A Comparison of Glucose and Additional Signals for Three Different Exercise Types in Adolescents with Type 1 Diabetes Using a Hybrid Closed-Loop SystemRowen Seckold, Carmel E Smart, David N O'Neal, et al.Diabetes Technology & Therapeutics|December 26, 2024
Current Treatment Options for Diabetic Retinal DiseaseRyan F Bloomquist, Doan Tam Bloomquist, Thomas W GardnerDiabetes Technology & Therapeutics|March 25, 2025
Glucose Control in Type 1 Diabetes after Pancreas Transplantation: Does Automated Delivery Offer Comparable Results?Martina Zahradnická, Lenka Nemétová, Michal Kahle, et al.Diabetes Technology & Therapeutics|November 26, 2024
A Telehealth Program Using Continuous Glucose Monitoring and a Connected Insulin Pen Cap in Nursing Homes for Older Adults with Insulin-Treated Diabetes: The Trescasas StudyFernando Gomez-Peralta, Cristina Abreu, Estefanía Santos, et al.Diabetes Technology & Therapeutics|October 10, 2024
Insulin Pump Use and Diabetic Ketoacidosis Risk in Type 1 Diabetes: Secular Trends over Four DecadesDalton R Budhram, Priya Bapat, Abdulmohsen Bakhsh, et al.Diabetes Technology & Therapeutics|October 24, 2024
Possible Glycemic Effects of Vagus Nerve Stimulation Evaluated by Continuous Glucose Monitoring in People with Diabetes and Autonomic Neuropathy: A Randomized, Sham-Controlled TrialHuda Kufaishi, Davide Bertoli, Ditte Smed Kornum, et al.Pageof 282